Health Care/Hospital Global News & Press Release Distribution

Health Care/Hospital

All
APAC

China Jo-Jo Drugstores Receives CHEO Award and Remains Top 100 Chinese Pharmaceutical Retail Company for 11 Years

HANGZHOU, China, Sept. 8, 2020 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced that the...

2020-09-08 20:30 21748

Seegene introduces a High-throughput 8-plex Test for Flu A, Flu B, RSV and COVID-19 with dual internal controls

SEOUL, South Korea, Sept. 8, 2020 /PRNewswire/ -- Seegene, Inc. introduced a single tube real-time RT-PCR assay, Allplex™ SARS-CoV-2/FluA/FluB/RSV Assay, which simultaneously detects and differentiates Flu A, Flu B, RSV A/B, and three different target genes of COVID-19 (S gene, RdRP gene and N ge...

2020-09-08 20:00 2488

I-Mab Announces Upcoming Participation at September Conferences

SHANGHAI and GAITHERSBURG, Md., Sept. 8, 2020 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced its participation in the following conferences in Septem...

2020-09-08 20:00 9382

Life After Covid-19: Big Questions on Medical and Bio-Engineering

DAEJEON, South Korea, Sept. 8, 2020 /PRNewswire/ -- On September 9, the Global Strategic Institute at KAIST will delve into innovative future strategies for the medical and bio-engineering sectors that have been disrupted by COVID-19. The forum will live stream via YouTube, KTV, and Naver TV from...

2020-09-08 15:52 2047

Life After Covid-19: Big Questions on Medical and Bio-Engineering

Transcenta Holding Announces Appointment of Dr. Charlie Qi as Senior Vice President of Global Clinical Development

SUZHOU, China, Sept.7, 2020 /PRNewswire/ -- Transcenta Holding Limited (Transcenta), a global biotherapeutics company with fully-integrated capabilities in discovery, development and manufacturing of antibody-based therapeutics, today announced the appointment of Dr.Charlie Qi as its Senior Vice...

2020-09-07 23:00 1735

Executive from Yuyu Pharma Receives Presidential Commendation for Gender Equality Employment

SEOUL, South Korea, Sept. 4, 2020 /PRNewswire/ -- Eugene Baik, Head of Production at Yuyu Pharma (CEORobert Wonsang Yu, KRX 000220), received the Presidential Commendation for contributions in leading the realization of gender equality employment. The award was given at the 2020 Gender Equality ...

2020-09-04 21:00 3856

Executive from Yuyu Pharma Receives Presidential Commendation for Gender Equality Employment

I-Mab Announces $418 Million Private Placement with Hillhouse Capital-Led Consortium

SHANGHAI and GAITHERSBURG, Md., Sept. 4, 2020 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced that it has entered into definitive subscription agreeme...

2020-09-04 19:01 11329

AbbVie and I-Mab Enter into Global Strategic Partnership for Differentiated Immuno-oncology Therapy

NORTH CHICAGO, Illinois and SHANGHAI, China, Sept. 4, 2020 /PRNewswire/ -- AbbVie (NYSE: ABBV) and I-Mab (Nasdaq: IMAB) announced today that AbbVie and I-Mab have signed a broad, global collaboration agreement for the development and commercialization of lemzoparlimab (also known as TJC4), an inn...

2020-09-04 19:00 10464

111, Inc. Partners with Baiyunshan Pharmaceutical Sales in Digital Medicine Innovation

SHANGHAI, Sept. 4, 2020 /PRNewswire/ -- On August 25, 111, Inc. ("111" or the "Company") (Nasdaq: YI), a company dedicated to digitally connecting patients with drugs and healthcare services inChina, and Guangzhou Baiyunshan Pharmaceutical Sales Co., Ltd. ("Baiyunshan Pharmaceutical Sales"), an ...

2020-09-04 18:22 10096

Alphamab Oncology announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to KN046 for the treatment of thymic epithelial tumor

SUZHOU, China, Sept. 3, 2020 /PRNewswire/ -- Alphamab Oncology (stock code: 9966 HK) announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to KN046, a recombinant humanized PD-L1/CTLA-4 bispecific antibody developed by Jiangsu Alphamab Biopharmaceuti...

2020-09-03 23:46 2217

As More Seniors Look to Age Independently, TCL Unveils the MOVETIME Family Watch to Help Keep Seniors Connected

BERLIN, Sept. 3, 2020 /PRNewswire/ -- TCL, one of the world's best-selling consumer electronics brands and leading technology companies, is introducing the MOVETIME Family Watch MT43A today. This 4G connected watch provides hands-free two way calling, automatic fall detection, heart rate monitori...

2020-09-03 21:15 10802

As More Seniors Look to Age Independently, TCL Unveils the MOVETIME Family Watch to Help Keep Seniors Connected

New investors Thiel and Novogratz introduced to Bionomics by Apeiron Investment Group as part of successful second placement capital raising

SYDNEY, Sept. 3, 2020 /PRNewswire/ -- Following overwhelming shareholder approval, the scheduled second placement of 54,333,000 new shares by Bionomics is proceeding and expected to complete shortly. In accordance with the Subscription Agreement between Apeiron and Bionomics, Apeiron has introduc...

2020-09-03 16:34 23776

New study demonstrates PICO™ Single Use Negative Pressure Wound Therapy System (sNPWT) beats standard dressings in reducing surgical site complications resulting in fewer deep sternal wound infections (DSWI) following cardiac surgery

LONDON, Sept. 3, 2020 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, announces the publication of a new study in cardiac surgery showing that PICO sNPWT significantly reduced the incidence of surgical site complications (SSCs) by 64%,* which resulted in a...

2020-09-03 15:00 10097

New study demonstrates PICO™ Single Use Negative Pressure Wound Therapy System (sNPWT) beats standard dressings in reducing surgical site complications resulting in fewer deep sternal wound infections (DSWI) following cardiac surgery

Guide IR Fever Warning Systems Help Canadian Schools Fight against COVID-19

CALGARY, Canada, Sept. 2, 2020 /PRNewswire/ -- Guide Sensmart ("the Company"), a world leading manufacturer of infrared thermal imaging systems has supplied its mass fever screening solutions to schools in Canada in the fight against the COVID-19 pandemic as students are returning to school. Gui...

2020-09-03 00:59 2077

NIH Awards MicroGEM up to $40.9M to Fast-Track Rapid, No-Lab COVID-19 Saliva Test

The U.S. company's molecular test simultaneously identifies presence of influenza types A and B CHARLOTTESVILLE, Virginia, Sept. 3, 2020 /PRNewswire/ -- MicroGEM today announced it has been awarded up to$40.9 million by the National Institutes of Health (NIH), Rapid Acceleration of Diagnostics (...

2020-09-02 23:05 2142

PharmAbcine is presenting at the KSMO 2020

DAEJEON, South Korea, Sept. 2, 2020 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotechnology company in South Korea, announced today that onSeptember 4th, the company will present the interim data of its ongoing IO combo clinical trials at KSMO 2020. KSMO 2020 is the...

2020-09-02 21:00 2108

PharmAbcine signs a CMO contract with Binex so Binex can produce olinvacimab at its new 5,000L production line

DAEJEON, South Korea, Sept. 2, 2020 /PRNewswire/ -- PharmAbcine (KRX: 208340ks), a biotech company focusing on the development of antibody therapeutics, announcedon August 31 that it had signed a contract manufacturing organization(CMO) agreement with Binex, a leading biologics CDMO(Contract Dev...

2020-09-02 21:00 1984

Cardiac Dimensions Announces Australian Therapeutic Goods Administration's Approval of the Carillon System for the Treatment of Functional Mitral Regurgitation

KIRKLAND, Washington, Sept. 2, 2020 /PRNewswire/ -- Cardiac Dimensions®, a leader in the development of innovative, minimally invasive treatments for functional mitral regurgitation (FMR) in patients with heart failure, today announced the Therapeutic Goods Administration (TGA) has approved its C...

2020-09-02 20:00 1500

Clene Nanomedicine, Inc. to go Public through Merger with Tottenham Acquisition I Limited

* Clene is a clinical-stage biopharmaceutical company developing the first potential therapeutic nanocatalyst, CNM-Au8, for treatment of neurodegenerative diseases with a Phase 3 study underway in amyotrophic lateral sclerosis (ALS), and concurrent Phase 2 clinical programs ongoing for the neur...

2020-09-02 20:00 18877

bitBiome has raised 700 million JPY in Seed financing

TOKYO, Sept. 1, 2020 /PRNewswire/ -- bitBiome, Inc., an emerging leader in microbiome analytics, has raised700 million JPY (approx. $6.6m US) in seed financing from previous and new investors including TheUniversity of Tokyo Edge Capital Partners, Universal Materials Incubator, and otherJapan-ba...

2020-09-02 11:28 1955

1 ... 255 256 257258259 260 261 ... 283